Sep 2026 · Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 27 Aug - Paradeep Phosphates to attend Elara Capital investor conference on September 1, 2026 in Mumbai.
Source: Bse
Chemicals stocks · Large cap · NSE
Paradeep Phosphates Limited (PPL) is India's leading private sector phosphatic fertilizer company with 3.7 MMTPA capacity across three plants. It produces DAP, NPK grades, and Urea, serving over 15 million farmers across 18 states. PPL also has an industrial portfolio of chemicals and other products.
SMA20 -3.4% / mo · MACD − · sector -4.2pp vs Nifty 500 (3M)
Latest mapped FPI equity flow was not positive. View sector evidence
Adjusted completed-session prices, rebased to 100
Investable fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend argues for patience, and recent execution is consistent.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue +36.0% · PAT +24.0% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Rev +36% YoY · PAT +24% YoY · +30% QoQ · margin compression
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹6,124 Cr | +36.0% | +30.2% |
| EBITDA | ₹720 Cr | +24.1% | +62.9% |
| Operating margin | 12.0% | -100 bps | +300 bps |
| PAT | ₹393 Cr | +24.0% | +151.9% |
| PAT margin | 6.4% | -62 bps | +310 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 20/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Signals are conflicting — long-term uptrend intact. RSI 40. Wait for confirmation.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 72 · legacy U-Score band UNDERVALUED · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +0 points.
Business-comparable peers in Chemicals — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
PPL reported robust FY26 performance with Revenue from Operations up 28.7% YoY to Rs. 218,263 Mn and EBITDA up 33.0% YoY to Rs. 22,594 Mn, driven by improved economies of scale and NPK category growth. Q4 FY26 saw revenue up 12.1% YoY but Net Profit declined 4.7% YoY.
PPL delivered strong full-year financial and operational growth, achieving 100% production capacity and expanding Sulphuric Acid capacity. Management's strategic focus on backward integration and value-added NPK products supports future growth, despite a Q4 PAT decline. The plan to reach 5.0 MMTPA total capacity by FY29 is a key positive.
NPK as a category (including TSP) grew by 22% in FY26.
Extensive pan-India distribution network across 18 states, 7,000 dealers, 100,000 retailers, and 15 million farmers.
Targeting 5.0 MMTPA total capacity by FY29, up from 3.7 MMTPA in FY26.
Plan to double Phosphoric Acid capacity from 0.5 MMTPA to 1 MMTPA is on track; endeavor to make all sites 100% backward integrated in Phos acid.
Commissioned Sulphuric Acid Plants at Paradeep (500,000 MTPA) and Mangalore (100,000 MTPA) in FY26, increasing company-level capacity by 0.6 MMTPA (45%).
Plan to double Phos Acid capacity from 0.5 MMTPA to 1 MMTPA is on track.
Reflecting the strength of its integrated manufacturing operations, diversified product portfolio, and efficient sourcing capabilities.
Extensive pan-India distribution network supported by strong farmer engagement and brand recognition (Jai Kisaan Navratna, Mangala).
Competitive edge in sourcing raw materials via long-term agreements and close proximity to ports, enhancing inbound logistics.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
Full-year (FY26) results are crucial for assessing overall performance and strategic direction, best compared YoY. Q4 results, also compared YoY, provide recent performance context. QoQ comparisons are available for financials and show sequential momentum.
FY26: 3,666,291 MT, 7.7% Y-o-Y.
FY26: 4,209,890 MT, 10.2% Y-o-Y.
FY26: 10.3%.
PPL achieved production of 37 lakh tonnes in FY26, achieving 100% capacity.
We remain focused on operational excellence, disciplined execution and sustainable growth.
Continuing to serve India’s farming community through a diversified product portfolio and strong distribution network.
Directionally we endeavour to make all our sites 100% backward integrated in Phos acid.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| Phosphoric Acid Capacity Expansion | Plan to double from 0.5 MMTPA to 1 MMTPA is on track. | Progress and commissioning timelines for the Phos Acid capacity doubling. |
| Total Capacity Utilization | Achieved 100% capacity utilization in FY26. | Sustained high utilization rates as new capacities come online. |
| Value-added NPK Growth | NPK (including TSP) grew by 22% in FY26. | Continued strong growth in value-added fertilizer categories. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 59th percentile of the scored universe and 36th percentile within Chemicals. Main check: cash conversion is weak at 52/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · Chemicals: 36th pctile, median 73 · Large: 35th pctile, median 73
60 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Company Ir
Source: Bse